BioSpace News Archive

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that Sergio Traversa, Chief Executive Officer of Relmada, will participate in a fireside chat at the 2021 SVB Leerink Global Healthcare Conference

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021:

Today, Bristol Myers Squibb (NYSE:BMY) and the American Music Therapy Association, a premier organization aimed at progressing the therapeutic use of music in rehabilitation, special education, and community settings1, announce their partnership with award-winning actor, singer and songwriter Ben Platt

Elicio Therapeutics, a private biotechnology company developing a pipeline of potent immunotherapies based on its proprietary lymph-node targeting Amphiphile technology, announced it has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration for ELI-002. ELI-002 is an Amphiphile

The American Academy of Thermology is a 501c(3) that promulgates the scientific application of medical thermology.

SMA is a devastating, debilitating, and often fatal disease for babies who are born with it. It is caused by a gene mutation that leads to difficulty performing the basic functions of life, like breathing and swallowing.

CureScienceTM Institute, a San Diego-based 501(c)(3) non-profit organization dedicated to accelerating novel curative therapies, announced today that Dr. Boris Reznik, has joined the organization’s Advisory Board

Sanofi Canada announced today that Health Canada has approved DUPIXENT® (dupilumab injection) for the treatment of moderate-to-severe atopic dermatitis (AD) in children aged six to 11 years whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.3

Dr. Olofsson will be working with our team in implementing our strategies for the commercialization of our products.

The compression therapy market is slated to register momentous gains driven by recent technological advancements and increasing awareness among today’s patients regarding the availability of different treatment options.